.Lykos CEO and founder Amy Emerson is actually leaving, with main working officer Michael Mullette t...
.Novartis is opening a brand new frontier in its collaboration with Voyager Therapeutics, paying out...
.On the heels of an FDA rejection for its own primary rival Novo Nordisk, Eli Lilly is actually pull...
.Merely a handful of months after application the 1st person in a period 2 test for freshly identifi...
.Eli Lilly's hunt for weight problems intendeds has actually led it to the darker genome. The Big Ph...
.Toolbox Biosciences is carrying on up. The cell treatment company has actually added on $325 thousa...
.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...
.Aelis Farma's hopes of securing a fast, favorable choice on a $100 thousand option settlement have ...
.ProKidney has actually stopped among a set of stage 3 trials for its tissue therapy for kidney heal...
.Vaxcyte unveiled what professionals named "sensational" stage 1/2 records for its own 31-valent pne...